Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2413360
Max Phase: Preclinical
Molecular Formula: C16H21N3O3
Molecular Weight: 303.36
Molecule Type: Small molecule
Associated Items:
ID: ALA2413360
Max Phase: Preclinical
Molecular Formula: C16H21N3O3
Molecular Weight: 303.36
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(NCCCOc1ccccc1)OCCCc1c[nH]cn1
Standard InChI: InChI=1S/C16H21N3O3/c20-16(22-10-4-6-14-12-17-13-19-14)18-9-5-11-21-15-7-2-1-3-8-15/h1-3,7-8,12-13H,4-6,9-11H2,(H,17,19)(H,18,20)
Standard InChI Key: WZUATPVPGCCNQR-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 303.36 | Molecular Weight (Monoisotopic): 303.1583 | AlogP: 2.54 | #Rotatable Bonds: 9 |
Polar Surface Area: 76.24 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 13.12 | CX Basic pKa: 6.57 | CX LogP: 1.73 | CX LogD: 1.68 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.70 | Np Likeness Score: -0.76 |
1. Sadek B, Shehab S, Więcek M, Subramanian D, Shafiullah M, Kieć-Kononowicz K, Adem A.. (2013) Anticonvulsant properties of histamine H3 receptor ligands belonging to N-substituted carbamates of imidazopropanol., 23 (17): [PMID:23891186] [10.1016/j.bmcl.2013.06.075] |
Source(1):